ShareThermo Scientific will be exhibiting at the 33rd ISICEM in Brussels and will be presenting its procalcitonin (PCT) biomarker. Early identification of sepsis is crucial to improving patient outcomes. Yet sepsis can be difficult to differentiate from nonbacterial infections. Procalcitonin (PCT) is a biomarker that exhibits a rapid, clinically significant response to severe bacterial infection. In patients with sepsis, PCT levels increase in correlation to the severity of the infection. Adding the PCT biomarker assay can help improve the accuracy of risk assessment in sepsis and guide therapeutic decisions.
About Thermo Scientific
BRAHMS GmbH, Part of Thermo Fisher Scientific, specialises in innovative products that facilitate earlier diagnosis of diseases and better control of therapy, thus enabling doctors to provide more efficient and economic patient care. Major fields of activity are diagnosis of infectious and thyroid diseases, cardiology and pneumology as well as sepsis, tumors, and Down's syndrome.To find out more please visit Thermo Scientific at ISICEM 2013, stand nr. 2.47 - 2.88 or visit: thermoscientific.com/procalcitonin
